Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 13.30
-0.30 (-2.21%)
May 8, 2026, 1:21 PM CST
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 612.8 million as of May 8, 2026. Its market cap has increased by 12.00% in one year.
Market Cap
612.80M
Enterprise Value
442.76M
Revenue
61.41M
Ranking
n/a
PE Ratio
6.39
Stock Price
13.30
Market Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has increased from 393.23M to 612.80M, an increase of 55.84%. That is a compound annual growth rate of 3.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 612.80M | - |
| Dec 31, 2025 | 612.80M | -3.45% |
| Dec 31, 2024 | 634.68M | -32.08% |
| Dec 29, 2023 | 934.52M | 49.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 1.06B |
| TCI GENE | 952.51M |
| Taiwan Advance Bio-Pharmaceutical | 945.00M |
| NatureWise Biotech & Medicals | 893.05M |
| MegaPro Biomedical | 847.84M |
| Neith | 793.51M |
| BioLASCO Taiwan | 755.55M |
| SynCore Biotechnology Co.,Ltd | 731.42M |